$1.210
-0.039 (-3.20%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
ALLO 相似圖表分析預測
Alphio's ALLO stock price prediction model matches the current Allogene Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.21 (+0.41%). The 1-week path is $1.19 (-1.79%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Allogene Therapeutics, Inc. 股票嗎？
Allogene Therapeutics is not a good buy right now. The current price is $1.25, with an RSI of 23.657 indicating the stock is oversold. The company reported a significant net loss of $42,677,000 in Q2 2026, and its forward P/E ratio is 0, suggesting no expected profitability in the near term. The main risk is the ongoing financial losses, which could hinder future growth and investor confidence.
ALLO 股價於 Monday 收在 $1.21，此前下跌 -3.20%
Allogene Therapeutics, Inc. (ALLO) last closed at $1.21, losing -3.20%. These facts feed the 1-day and 1-week ALLO price prediction above.
分析師一致預期
Allogene Therapeutics, Inc.（ALLO）：買進 3、持有 1、賣出 0。展望：Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
預測驅動因素
Allogene Therapeutics, Inc.（ALLO）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
相似圖表形態
近期走勢與 ALLO 最接近的股票，依相似度排序。
ALLO 季節性分析
Historically the probability of a positive October return for ALLO is 12.50%. February offers the highest probability of a positive month at 72.41%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。